GB/T 43278-2023 English PDFUS$1324.00 · In stock
Delivery: <= 8 days. True-PDF full-copy in English will be manually translated and delivered via email. GB/T 43278-2023: Medical laboratories - Application of risk management to medical laboratories Status: Valid
Basic dataStandard ID: GB/T 43278-2023 (GB/T43278-2023)Description (Translated English): Medical laboratories - Application of risk management to medical laboratories Sector / Industry: National Standard (Recommended) Classification of Chinese Standard: C30 Classification of International Standard: 11.100.01 Word Count Estimation: 73,775 Date of Issue: 2023-11-27 Date of Implementation: 2024-06-01 Issuing agency(ies): State Administration for Market Regulation, China National Standardization Administration GB/T 43278-2023: Medical laboratories - Application of risk management to medical laboratories---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.ICS 11:100:01 CCSC30 National Standards of People's Republic of China medical laboratory Application of risk management in medical laboratories Medicallaboratories- (ISO 22367:2020,IDT) Published on 2023-11-27 2024-06-01 Implementation State Administration for Market Regulation Released by the National Standardization Administration Committee Table of contentsPreface III Introduction IV 1 Scope 1 2 Normative references 1 3 Terms and Definitions 1 4 Risk Management 7 5 Risk Analysis11 6 Risk Assessment13 7 Risk Control14 8 Benefit-Risk Analysis 15 9 Risk Management Review16 10 Risk monitoring, analysis and control activities16 Appendix A (informative) Implementing risk management in the quality management system 19 Appendix B (informative) Developing a risk management plan 27 Appendix C (Informative) Risk Acceptability Analysis 29 Appendix D (informative) Identification of safety-related characteristics 31 Appendix E (informative) Examples of hazards, foreseeable sequences of events and hazardous situations37 Appendix F (informative) Non-conformities that may lead to significant risks 43 Appendix G (Informative) Risk Analysis Tools and Techniques 49 Appendix H (Informative) Risk Analysis of Predictable User Behavior53 Appendix I (informative) Risk assessment methods, including estimates of hazard probability and severity57 Appendix J (informative) Total residual risk assessment and risk management review 62 Appendix K (informative) Conducting a benefit-risk analysis 64 Appendix L (Informative) Residual Risk 66 Reference 67ForewordThis document complies with the provisions of GB/T 1:1-2020 "Standardization Work Guidelines Part 1: Structure and Drafting Rules of Standardization Documents" Drafting: This document is equivalent to ISO 22367:2020 "Application of Medical Laboratory Risk Management in Medical Laboratories": Please note that some content in this document may be subject to patents: The publisher of this document assumes no responsibility for identifying patents: This document is proposed by the National Medical Products Administration: This document is under the jurisdiction of the National Standardization Technical Committee for Medical Clinical Laboratory and In Vitro Diagnostic Systems (SAC/TC136): This document was drafted by: China National Accreditation Center for Conformity Assessment, Beijing Institute of Medical Device Inspection (Beijing Medical Biological Protection Equipment Inspection and Research Center), Guangdong Provincial Hospital of Traditional Chinese Medicine, Second Medical Center of the Chinese People's Liberation Army General Hospital, Second Xiangya Hospital of Central South University, Fujian Union Hospital Affiliated to Medical University, Shanghai Oriental Hospital (Oriental Hospital Affiliated to Tongji University), Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Beijing Beijing Red Cross Blood Center: The main drafters of this document: Hu Dongmei, Fu Yue, Bi Chunlei, Xu Ning, Deng Xinli, Hu Min, Cao Yingping, Wu Wenjuan, Fan Xiangshan, Ge Hongwei:IntroductionThis document provides a framework for medical laboratories whose experience, insights and judgment can be used to manage the risks associated with laboratory testing: The risk management process covers the full scope of medical laboratory services: pre-test, test and post-test processes, including the design and development: ISO 15189 requires medical laboratories to review their work processes, assess the impact of potential failures on test results, and modify processes to reduce or Eliminate identified risks and document decisions and actions taken: This document describes the process for managing these security risks, focusing on patient not only operators and other personnel, equipment and other property, but also the environment: It does not address business operations covered by ISO 31000 risk: Medical laboratories often rely on the use of in vitro medical devices to achieve their quality goals: Therefore, risk management is essential for in vitro diagnostic medical devices The shared responsibility of the (IVD) manufacturer and the medical laboratory: Since most IVD manufacturers have implemented YY/T 0316-2016, this article This document uses the same concepts, principles and framework as YY/T 0316-2016 to manage risks associated with medical laboratories: Medical laboratory activities expose patients, staff or other interested parties to a variety of hazards that may directly or indirectly result in varying degrees of harm: The concept of risk has two components: a) Probability of hazard occurrence; b) The consequences of the hazard, that is, the possible severity of the hazard: Risk management is complex because each stakeholder may assign different weights to the risk of harm: This document and ISO 14971 is consistent with the Global Harmonization Task Force (GHTF) guidance and is intended to facilitate laboratories, IVD manufacturers, regulatory agencies, accreditation bodies, and others Risk communication and collaboration among stakeholders benefit patients, laboratories, and public health: Medical laboratories are accustomed to focusing on detection errors, which are usually the result of use errors in daily work: Usage errors possible It is due to poor design of the instrument working interface or insufficient information provided by the manufacturer; it may also be caused by reasonably foreseeable misuse, such as Intentional failure to follow the IVD manufacturer's instructions for use or failure to follow generally accepted medical laboratory practices: These errors may cause or lead to dangerous Risks may appear immediately as independent events, or they may appear multiple times throughout the system, or they may remain latent until other secondary events: occur: The emerging field of usability engineering treats all of these "human factors" as preventable "usage errors:" In addition, the laboratory needs Respond to occasional failures when IVD medical devices operate as intended: Risks arising from equipment failure and usage errors, regardless of the cause can be proactively managed: Risk management is integrated with quality management in many elements of ISO 15189, in particular complaints management, internal audits, corrective actions, Preventive measures, safety checklists, quality control, management reviews, external reviews (including accreditation and proficiency testing): At the same time, risk management and medicine The laboratory has consistent safety management, such as the safety checklist in ISO 15190: Risk management is a planned and systematic process that is best implemented through a structured framework: This document is intended to assist medical laboratories Integrate risk management into its daily organization, operations and management: medical laboratory Application of risk management in medical laboratories1 ScopeThis document sets out the requirements for medical laboratories to identify and manage the risks associated with their examinations for patients, laboratory staff and service providers: the process of: This process includes the identification, estimation, evaluation, control and monitoring of risks: The requirements of this document apply to all aspects of medical laboratory testing and services, including pre-inspection, inspection and post-inspection aspects: accurate transmission of test results to electronic medical records, as well as other technical and management processes included in ISO 15189: This document does not specify an acceptable level of risk: This document does not apply to the risk of clinical decisions made by medical staff after testing: This document does not apply to the management of risks affecting medical laboratory operations covered by ISO 31000, such as commercial, economic, legal and regulatory risk:2 Normative reference documentsThis document has no normative references:3 Terms and definitionsThe following terms and definitions apply to this document: ISO and IEC maintain terminology databases used for standardization at: ---ISO online browsing platform: available at https://www:iso:org/obp; 3:1 benefit benefit The positive impact or desired outcome of a process (3:19), procedure (3:17) or use of a medical device on an individual’s health, or on patient management or the public positive effects on health: Note: Benefits include increased lifespan, reduced pain (symptom relief), improved function, or better health: 3:2 eventevent The occurrence or change of a certain type of situation: Note 1: An event may be the occurrence of one or more circumstances and may be caused by multiple reasons: Note 2: Events may include situations that did not occur: Note 3: Events may sometimes be referred to as "incidents" or "accidents": Note 4: Events without consequences may also be referred to as "near misses", "accidents", "imminent harm" or "near misses": [Source: GB/T 23694-2013,4:5:1:3] 3:3 examination A set of operations for the purpose of determining the value or characteristics of a property: ......Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of GB/T 43278-2023_English be delivered?Answer: Upon your order, we will start to translate GB/T 43278-2023_English as soon as possible, and keep you informed of the progress. The lead time is typically 5 ~ 8 working days. The lengthier the document the longer the lead time.Question 2: Can I share the purchased PDF of GB/T 43278-2023_English with my colleagues?Answer: Yes. The purchased PDF of GB/T 43278-2023_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet.Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. If you need your currency to be printed on the invoice, please write an email to Sales@ChineseStandard.net. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay. |
